» Articles » PMID: 23984091

Some Haematological and Biochemical Investigations on Duck Virus Hepatitis Following Administration of Glycyrrhizin

Overview
Journal ISRN Pharmacol
Date 2013 Aug 29
PMID 23984091
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed to investigate the protective effect of glycyrrhizin (locally isolated and purified from licorice root) against duck hepatitis virus through the assessment of some hematological and biochemical parameters. One hundred and sixty white Pekin ducklings-one day old-were randomly divided into four equal groups. Group (1) was kept as normal control. Group (2) was inoculated I/P with 10 mg glycyrrhizin/kg BW, three times per week for four weeks. Group (3) was inoculated I/M with 0.5 ml of live attenuated DHV vaccine. Group (4) was inoculated with both glycyrrhizin (10 mg/kg BW I/P, three times per week for four weeks) and live attenuated DHV vaccine (0.5 ml, I/M). Then, all groups of treatment were challenged using virulent DHV except for 20 ducklings from the normal control group which were continued to be kept as negative control. The results revealed that duck hepatitis virus (DHV) caused macrocytic hypochromic anemia, leukopenia, hypoproteinemia, hypoalbuminemia, hyperglycemia, hypercholesterolemia, and marked elevation of liver enzymes and renal parameters. In conclusion, glycyrrhizin injected alone or in combination with DHV vaccine protected or ameliorated the deteriorating effects induced by DHV vaccine and/or duck hepatitis virus infection by improvement of erythrogram and leukogram, as well as liver and kidney functions.

Citing Articles

Mitigating impact of Glycyrrhiza glabra on virulent Newcastle disease virus challenge in chickens: clinical studies, histopathological alterations and molecular docking.

Haleem M, Gaballa M, El-Far A, Taie H, Elshopakey G Vet Res Commun. 2024; 48(6):3823-3845.

PMID: 39316350 PMC: 11538193. DOI: 10.1007/s11259-024-10530-w.


Research Progress on the Antiviral Activity of Glycyrrhizin and its Derivatives in Liquorice.

Huan C, Xu Y, Zhang W, Guo T, Pan H, Gao S Front Pharmacol. 2021; 12:680674.

PMID: 34295250 PMC: 8290359. DOI: 10.3389/fphar.2021.680674.


Comparative Pathogenicity of Duck Hepatitis A Virus-1 Isolates in Experimentally Infected Pekin and Muscovy Ducklings.

Hisham I, Ellakany H, Selim A, Abdalla M, Zain El-Abideen M, Kilany W Front Vet Sci. 2020; 7:234.

PMID: 32671102 PMC: 7326108. DOI: 10.3389/fvets.2020.00234.


Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?.

Bailly C, Vergoten G Pharmacol Ther. 2020; 214:107618.

PMID: 32592716 PMC: 7311916. DOI: 10.1016/j.pharmthera.2020.107618.


Glycyrrhizin protects mice against renal ischemia-reperfusion injury through inhibition of apoptosis and inflammation by downregulating p38 mitogen-activated protein kinase signaling.

Ye S, Zhu Y, Ming Y, She X, Liu H, Ye Q Exp Ther Med. 2014; 7(5):1247-1252.

PMID: 24940420 PMC: 3991492. DOI: 10.3892/etm.2014.1570.

References
1.
Fujisawa Y, Sakamoto M, Matsushita M, Fujita T, Nishioka K . Glycyrrhizin inhibits the lytic pathway of complement--possible mechanism of its anti-inflammatory effect on liver cells in viral hepatitis. Microbiol Immunol. 2000; 44(9):799-804. DOI: 10.1111/j.1348-0421.2000.tb02566.x. View

2.
Abe M, Akbar F, Hasebe A, Horiike N, Onji M . Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis. J Gastroenterol. 2003; 38(10):962-7. DOI: 10.1007/s00535-003-1179-7. View

3.
Soufy H, Yassein S, Ahmed A, Khodier M, Kutkat M, Nasr S . Antiviral and immune stimulant activities of glycyrrhizin against duck hepatitis virus. Afr J Tradit Complement Altern Med. 2013; 9(3):389-95. PMC: 3746675. DOI: 10.4314/ajtcam.v9i3.14. View

4.
Boll M, WEBER L, Becker E, Stampfl A . Mechanism of carbon tetrachloride-induced hepatotoxicity. Hepatocellular damage by reactive carbon tetrachloride metabolites. Z Naturforsch C J Biosci. 2001; 56(7-8):649-59. DOI: 10.1515/znc-2001-7-826. View

5.
Haddad P, Depot M, Settaf A, Cherrah Y . Use of antidiabetic plants in Morocco and Québec. Diabetes Care. 2001; 24(3):608-9. DOI: 10.2337/diacare.24.3.608-a. View